Skip to main content

Lisdexamfetamine Dimesylate Tablet, Chewable Shortage

Last Updated: September 15, 2025
Status: Current

Limited Availability, Current:

Available, Current:

Lisdexamfetamine Dimesylate, Tablet, Chewable, 10 mg (Sun Pharmaceutical Industries, Inc.)

NDC Code: 57664-083-88
Availability: Limited Availability
Status: Current
Date of update: September 5, 2025
Update type: Revised
Reason for shortage: Other
Related Information: Available Q3 2025
Therapeutic category: Psychiatry
Initial posting date: July 14, 2023
Contact info: 800-818-4555

Lisdexamfetamine Dimesylate, Tablet, Chewable, 20 mg (Sun Pharmaceutical Industries, Inc.)

NDC Code: 57664-084-88
Availability: Limited Availability
Status: Current
Date of update: September 5, 2025
Update type: Revised
Reason for shortage: Other
Related Information: Available Q3 2025
Therapeutic category: Psychiatry
Initial posting date: July 14, 2023
Contact info: 800-818-4555

Lisdexamfetamine Dimesylate, Tablet, Chewable, 30 mg (Sun Pharmaceutical Industries, Inc.)

NDC Code: 57664-085-88
Availability: Limited Availability
Status: Current
Date of update: September 5, 2025
Update type: Revised
Reason for shortage: Other
Related Information: Available Q3 2025
Therapeutic category: Psychiatry
Initial posting date: July 14, 2023
Contact info: 800-818-4555

Lisdexamfetamine Dimesylate, Tablet, Chewable, 40 mg (Sun Pharmaceutical Industries, Inc.)

NDC Code: 57664-086-88
Availability: Limited Availability
Status: Current
Date of update: September 5, 2025
Update type: Revised
Reason for shortage: Other
Related Information: Available Q3 2025
Therapeutic category: Psychiatry
Initial posting date: July 14, 2023
Contact info: 800-818-4555

Lisdexamfetamine Dimesylate, Tablet, Chewable, 50 mg (Sun Pharmaceutical Industries, Inc.)

NDC Code: 57664-087-88
Availability: Limited Availability
Status: Current
Date of update: September 5, 2025
Update type: Revised
Reason for shortage: Other
Related Information: Available Q3 2025
Therapeutic category: Psychiatry
Initial posting date: July 14, 2023
Contact info: 800-818-4555

Lisdexamfetamine Dimesylate, Tablet, Chewable, 60 mg (Sun Pharmaceutical Industries, Inc.)

NDC Code: 57664-088-88
Availability: Limited Availability
Status: Current
Date of update: September 5, 2025
Update type: Revised
Reason for shortage: Other
Related Information: Available Q3 2025
Therapeutic category: Psychiatry
Initial posting date: July 14, 2023
Contact info: 800-818-4555

Lisdexamfetamine Dimesylate, Tablet, Chewable, 10 mg (Novadoz Pharmaceuticals LLC)

NDC Code: 72205-132-91
Availability: Available
Status: Current
Date of update: September 15, 2025
Update type: Revised
Reason for shortage: Shortage of an active ingredient
Therapeutic category: Psychiatry
Initial posting date: July 14, 2023
Contact info: (855) 668-2369; customerservice@novadozpharma.com

Lisdexamfetamine Dimesylate, Tablet, Chewable, 20 mg (Novadoz Pharmaceuticals LLC)

NDC Code: 72205-133-91
Availability: Available
Status: Current
Date of update: September 15, 2025
Update type: Revised
Reason for shortage: Shortage of an active ingredient
Therapeutic category: Psychiatry
Initial posting date: July 14, 2023
Contact info: (855) 668-2369; customerservice@novadozpharma.com

Lisdexamfetamine Dimesylate, Tablet, Chewable, 30 mg (Novadoz Pharmaceuticals LLC)

NDC Code: 72205-134-91
Availability: Available
Status: Current
Date of update: September 15, 2025
Update type: Revised
Reason for shortage: Shortage of an active ingredient
Therapeutic category: Psychiatry
Initial posting date: July 14, 2023
Contact info: (855) 668-2369; customerservice@novadozpharma.com

Lisdexamfetamine Dimesylate, Tablet, Chewable, 40 mg (Novadoz Pharmaceuticals LLC)

NDC Code: 72205-135-91
Availability: Available
Status: Current
Date of update: September 15, 2025
Update type: Revised
Reason for shortage: Shortage of an active ingredient
Therapeutic category: Psychiatry
Initial posting date: July 14, 2023
Contact info: (855) 668-2369; customerservice@novadozpharma.com

Lisdexamfetamine Dimesylate, Tablet, Chewable, 50 mg (Novadoz Pharmaceuticals LLC)

NDC Code: 72205-136-91
Availability: Available
Status: Current
Date of update: September 15, 2025
Update type: Revised
Reason for shortage: Shortage of an active ingredient
Therapeutic category: Psychiatry
Initial posting date: July 14, 2023
Contact info: (855) 668-2369; customerservice@novadozpharma.com

Lisdexamfetamine Dimesylate, Tablet, Chewable, 60 mg (Novadoz Pharmaceuticals LLC)

NDC Code: 72205-137-91
Availability: Available
Status: Current
Date of update: September 15, 2025
Update type: Revised
Reason for shortage: Shortage of an active ingredient
Therapeutic category: Psychiatry
Initial posting date: July 14, 2023
Contact info: (855) 668-2369; customerservice@novadozpharma.com

Vyvanse, Tablet, Chewable, 10 mg (Takeda Pharmaceuticals USA Inc.)

NDC Code: 59417-115-01
Availability: Available
Status: Current
Date of update: August 15, 2025
Update type: Reverified
Therapeutic category: Psychiatry
Initial posting date: July 14, 2023
Contact info: 877-TAKEDA-7 (1-877-825-3327)

Vyvanse, Tablet, Chewable, 20 mg (Takeda Pharmaceuticals USA Inc.)

NDC Code: 59417-116-01
Availability: Available
Status: Current
Date of update: August 15, 2025
Update type: Reverified
Therapeutic category: Psychiatry
Initial posting date: July 14, 2023
Contact info: 877-TAKEDA-7 (1-877-825-3327)

Vyvanse, Tablet, Chewable, 30 mg (Takeda Pharmaceuticals USA Inc.)

NDC Code: 59417-117-01
Availability: Available
Status: Current
Date of update: August 15, 2025
Update type: Reverified
Therapeutic category: Psychiatry
Initial posting date: July 14, 2023
Contact info: 877-TAKEDA-7 (1-877-825-3327)

Vyvanse, Tablet, Chewable, 40 mg (Takeda Pharmaceuticals USA Inc.)

NDC Code: 59417-118-01
Availability: Available
Status: Current
Date of update: August 15, 2025
Update type: Reverified
Therapeutic category: Psychiatry
Initial posting date: July 14, 2023
Contact info: 877-TAKEDA-7 (1-877-825-3327)

Vyvanse, Tablet, Chewable, 50 mg (Takeda Pharmaceuticals USA Inc.)

NDC Code: 59417-119-01
Availability: Available
Status: Current
Date of update: August 15, 2025
Update type: Reverified
Therapeutic category: Psychiatry
Initial posting date: July 14, 2023
Contact info: 877-TAKEDA-7 (1-877-825-3327)

Vyvanse, Tablet, Chewable, 60 mg (Takeda Pharmaceuticals USA Inc.)

NDC Code: 59417-120-01
Availability: Available
Status: Current
Date of update: August 15, 2025
Update type: Reverified
Therapeutic category: Psychiatry
Initial posting date: July 14, 2023
Contact info: 877-TAKEDA-7 (1-877-825-3327)

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Medical Disclaimer